George C. Butler
Plus aucun poste en cours
Profil
George C.
Butler is a professional with a doctorate degree from The University of Manchester.
He is currently employed at Eversheds Sutherland Legal Services Ltd.
as of 2004.
Prior to this, he held positions at SingEval Pte Ltd.
as Chairman & President, Bionovo, Inc. as Director from 2008 to 2011, AstraZeneca PLC as VP-Customer Relationships & Global Development, and Novartis AG as Vice President & Head-Regulatory Affairs.
Anciens postes connus de George C. Butler
| Sociétés | Poste | Fin |
|---|---|---|
SingEval Pte Ltd.
 SingEval Pte Ltd. BiotechnologyHealth Technology SingEval Pte Ltd. engages in pharmaceuticals services. The company is headquartered in Singapore. | Président | 01/02/2009 |
| ASTRAZENECA PLC | Public Communications Contact | 14/04/2011 |
| NOVARTIS AG | Conseiller Juridique Général | - |
| BIONOVO INC. | Directeur/Membre du Conseil | - |
Formation de George C. Butler
| The University of Manchester | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| NOVARTIS AG | Health Technology |
| Entreprise privées | 2 |
|---|---|
Bionovo, Inc.
 Bionovo, Inc. Pharmaceuticals: MajorHealth Technology Bionovo, Inc. is a clinical drug discovery and development company, which is focused on developing drugs for the treatment of unmet medical needs in women's health and cancer. The company was founded by Isaac Cohen and Mary Tagliaferri in February 2002 and is headquartered in Emeryville, CA. | Health Technology |
SingEval Pte Ltd.
SingEval Pte Ltd. BiotechnologyHealth Technology SingEval Pte Ltd. engages in pharmaceuticals services. The company is headquartered in Singapore. | Health Technology |